Overview

Effect of Remazolam Besylate Combined With Remifentanil Analgesic Sedation on the Prognosis of Patients With Sepsis

Status:
ENROLLING_BY_INVITATION

Trial end date:
2025-12-31

Target enrollment:

Participant gender:

Summary

In this study, midazolam was used as a control to investigate the effect of remazolam besylate combined with remifentanil on analgesia and sedation in patients with mechanical ventilation of sepsis on the prognosis of patients, and to provide evidence for the safe application of remazolam besylate in patients with sepsis.

Phase:

PHASE4

Details

Lead Sponsor:

First Affiliated Hospital of Ningbo University

Treatments:

Midazolam